BMRN

BioMarin Pharmaceutical (BMRN)

BioMarin Pharmaceutical Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:BMRN

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/03/08	06:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2025/03/08	06:03	Edgar (US Regulatory)	Form 3/A - Initial statement of beneficial ownership of securities: [Amend]	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2025/03/07	06:05	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2025/03/05	06:11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2025/03/04	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2025/02/28	09:19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2025/02/28	09:17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2025/02/28	09:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2025/02/27	06:18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2025/02/27	06:14	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2025/02/26	10:21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2025/02/25	23:00	PR Newswire (US)	BioMarin to Present at the TD Cowen 45th Annual Healthcare Conference on Tuesday, March 4 at 6:50 AM PT / 9:50 AM ET in Boston, MA	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2025/02/25	06:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2025/02/25	06:05	PR Newswire (US)	BioMarin Announces Appointment of Timothy P. Walbert to Board of Directors	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2025/02/25	03:54	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2025/02/25	00:26	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2025/02/20	06:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2025/02/20	06:05	PR Newswire (US)	BioMarin Reports Fourth Quarter and Full Year 2024 Results; Sets Full Year 2025 Guidance	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2025/02/14	04:14	Edgar (US Regulatory)	Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2025/02/05	23:00	PR Newswire (US)	BioMarin to Host Fourth Quarter and Full-Year 2024 Financial Results Conference Call and Webcast on Wednesday, February 19, 2025, at 4:30pm ET	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2025/01/14	02:00	PR Newswire (US)	BioMarin Announces Legal Action Against Ascendis Pharma A/S in European Unified Patent Court	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2025/01/06	22:30	PR Newswire (US)	BioMarin to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, at 9:00 am PT / 12:00 pm ET, in San Francisco, CA	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2024/12/04	08:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2024/11/17	00:45	PR Newswire (US)	BioMarin Presents Real-World Evidence Further Supporting Safety and Efficacy of VOXZOGO® (vosoritide) in Children with Achondroplasia at the European Society for Paediatric Endocrinology (ESPE) Meeting 2024	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2024/11/15	04:44	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2024/11/13	04:27	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2024/11/06	22:00	PR Newswire (US)	BioMarin to Participate in Three Upcoming Investor Conferences	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2024/11/01	04:01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2024/10/30	05:04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BMRN	BioMarin Pharmaceutical Inc
2024/10/30	05:03	PR Newswire (US)	BioMarin Announces 28% Y/Y Total Revenue Growth in the Third Quarter and Increase in Full-year 2024 Guidance; Reaffirms Long-term Guidance and Outlook	NASDAQ:BMRN	BioMarin Pharmaceutical Inc